Latest filing published 20 Aug 2026 for Interpace Biosciences, INC..
Insider track record
No signal scores available.
Christopher McCarthy: trading record in brief
This profile gathers the share dealings of Christopher McCarthy in Interpace Biosciences, Inc. The record holds 9 filings, for trades running from 31 July 2023 to 20 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 20 August 2026 came the latest disclosure, an option exercise in Interpace Biosciences, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher McCarthy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 277,009 shares0Common StockSEC:0001493152-26-039495:0
- 7,556 shares0Common StockSEC:0001641172-25-006211:0
- 10,000 shares0Common StockSEC:0001493152-24-005018:0
- 25,000 shares0Common StockSEC:0001493152-23-026319:0
4 of 4 declarations